Basilea Pharmaceutica AG (BSLN) — Cash Flow-to-Debt Ratio
Basilea Pharmaceutica AG (BSLN) has a Cash Flow-to-Debt Ratio of 0.25x as of December 2025, meaning its operating cash flow of CHF39.03 Million could theoretically repay 0% of its total liabilities (CHF154.06 Million) in one year. Explore how much of Basilea Pharmaceutica AG's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Basilea Pharmaceutica AG Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Basilea Pharmaceutica AG across 24 annual periods. Also explore Basilea Pharmaceutica AG asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Basilea Pharmaceutica AG (2002–2025)
Year-by-year debt coverage analysis for Basilea Pharmaceutica AG. For market capitalisation and broader financial context, see Basilea Pharmaceutica AG market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CHF62.09 Million | CHF154.06 Million | ▼ -4.2% |
| 2024 | 0.42x | CHF74.36 Million | CHF176.76 Million | ▲ +441.3% |
| 2023 | 0.08x | CHF14.24 Million | CHF183.29 Million | ▲ +166.1% |
| 2022 | 0.03x | CHF7.06 Million | CHF241.56 Million | ▲ +127.9% |
| 2021 | -0.10x | CHF-32.02 Million | CHF305.87 Million | ▲ +35.8% |
| 2020 | -0.16x | CHF-54.13 Million | CHF331.84 Million | ▲ +19.6% |
| 2019 | -0.20x | CHF-63.84 Million | CHF314.43 Million | ▲ +10.7% |
| 2018 | -0.23x | CHF-79.21 Million | CHF348.44 Million | ▼ -569.4% |
| 2017 | 0.05x | CHF19.01 Million | CHF392.61 Million | ▲ +123.4% |
| 2016 | -0.21x | CHF-75.00 Million | CHF362.76 Million | ▼ -17.1% |
| 2015 | -0.18x | CHF-67.78 Million | CHF383.88 Million | ▲ +50.7% |
| 2014 | -0.36x | CHF-71.46 Million | CHF199.45 Million | ▼ -37.9% |
| 2013 | -0.26x | CHF-59.47 Million | CHF228.88 Million | ▼ -147.3% |
| 2012 | 0.55x | CHF148.17 Million | CHF269.84 Million | ▲ +155.9% |
| 2011 | -0.98x | CHF-82.38 Million | CHF83.82 Million | ▼ -198.0% |
| 2010 | 1.00x | CHF106.64 Million | CHF106.30 Million | ▲ +195.4% |
| 2009 | -1.05x | CHF-114.51 Million | CHF108.88 Million | ▼ -6.2% |
| 2008 | -0.99x | CHF-127.17 Million | CHF128.38 Million | ▼ -58.4% |
| 2007 | -0.63x | CHF-78.99 Million | CHF126.34 Million | ▲ +21.7% |
| 2006 | -0.80x | CHF-72.47 Million | CHF90.78 Million | ▼ -303.6% |
| 2005 | 0.39x | CHF34.38 Million | CHF87.69 Million | ▲ +112.9% |
| 2004 | -3.03x | CHF-64.20 Million | CHF21.18 Million | ▲ +3.3% |
| 2003 | -3.13x | CHF-52.42 Million | CHF16.73 Million | ▼ -22.9% |
| 2002 | -2.55x | CHF-64.07 Million | CHF25.13 Million | — |